ALGEZIKAM is a nonsteroidal anti-inflammatory drug  for rapid, long and safe relief of inflammatory diseases of the musculoskeletal system, combining high quality with a reasonable price.

Manifestations of anti-inflammatory, analgesic and antipyretic effects.

Indications for use:

Short-term symptomatic treatment for acute attack of rheumatoid arthritis and ankylosing spondylitis, when the oral and rectal routes of administration can not be applied.


  • third trimester of pregnancy;
  • age of the patient under 18 years;
  • hypersensitivity to the active substance or to other components of the medicinal product;
  • hypersensitivity to active substances with similar effects, such as nonsteroidal anti-inflammatory drugs , acetylsalicylic acid. Meloxicam should not be prescribed to patients who have symptoms of asthma, nasal polyps, angioedema or urticaria after taking acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs ;
  • gastrointestinal bleeding or perforation related to previous therapy  of  nonsteroidal anti-inflammatory drugs in the in anamnesis;
  • active or relapsing peptic ulcer / bleeding in anamnesis  (two or more certain confirmed cases of ulceration or bleeding);
  • severe liver failure;
  • severe renal failure without dialysis;
  • gastrointestinal bleeding, cerebrovascular bleeding in anamnesis  or other disorders of blood clotting;
  • hemostasis disorders or the simultaneous use of anticoagulants (Contraindications associated with the route of application);
  • severe heart failure;
  • treatment of perioperative pain in coronary bypass.